Computational design of CYP102A1 variants for the biosynthesis of a next-generation antiplatelet drug DT-678
Sun YuDong, Xiaoqiang Huang, Jifeng Zhang, Yoichi Osawa, Y. Eugene Chen, H. Zhang
This paper designs CYP102A1 variants to biosynthesize the antiplatelet drug DT-678, showing improved catalytic activity and productivity with ascorbic acid protection.
ACS Synthetic Biology · Mar 6, 2026Peer-reviewedBiochemistry